Influence of Insulin-Sensitizers in Type 2 Diabetes Mellitus Patients Glargine Therapy

被引：0
作者：
Constantin, Ciprian
Constantin, Georgiana
Cheta, Dan
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2559-PO
引用
收藏
页码：A674 / A675
页数：2
相关论文
共 50 条
  • [21] EFFECTIVENESS OF TITRATION ALGORITHMS WITH INSULIN GLARGINE IN PATIENTS WITH TYPE-2 DIABETES MELLITUS
    Pfuetzner, A.
    Stratmann, B.
    Funke, K.
    Pohlmeier, H.
    Rose, L.
    Sieber, J.
    Flacke, F.
    Forst, T.
    Tschoepe, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A28 - A28
  • [22] Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus
    Ilag, L. L.
    Deeg, M. A.
    Costigan, T.
    Hollander, P.
    Blevins, T. C.
    Edelman, S. V.
    Konrad, R. J.
    Ortmann, R. A.
    Pollom, R. K.
    Huster, W. J.
    Zielonka, J. S.
    Prince, M. J.
    DIABETES OBESITY & METABOLISM, 2016, 18 (02) : 159 - 168
  • [23] Early insulin therapy in patients with type 2 diabetes mellitus
    Mashitisho, M. L. I.
    Mashitisho, B. G.
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2016, 21 (01) : 13 - 15
  • [24] Intensifying insulin therapy in patients with type 2 diabetes mellitus
    Hirsch, IB
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 : 21 - 26
  • [25] The Future of Insulin Therapy for Patients With Type 2 Diabetes Mellitus
    Tibaldi, Joseph M.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2013, 113 (04): : S29 - S39
  • [26] COST-EFFECTIVENESS OF INSULIN DEGLUDEC COMPARED WITH INSULIN GLARGINE FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATING INSULIN THERAPY IN THE UNITED KINGDOM
    Evans, M.
    Chubb, B.
    Christensen, T.
    Gundgaard, J.
    Wolden, M.
    VALUE IN HEALTH, 2013, 16 (07) : A442 - A442
  • [27] Advantages of therapy with glargine insulin and metformin versus NPH insulin and metformin in patients with diabetes mellitus type2 associated obesity
    Moldovan, C.
    Vatc, L.
    Farca, D.
    Demian, L.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S128 - S128
  • [28] Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
    Liu, Dan
    Bai, Jing-Jie
    Yao, Jun-Jie
    Wang, Yong-Bo
    Chen, Tong
    Xing, Qian
    Bai, Ran
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1909 - 1917
  • [29] Characteristics and prescription behaviour of insulin glargine users among patients with type 2 diabetes mellitus
    Huang, X.
    Fan, C. -P. S.
    Li, Z.
    Hanna, B.
    Tang, J.
    Williams, J.
    DIABETOLOGIA, 2015, 58 : S188 - S188
  • [30] COMPARISON OF COSTS OF THE INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS WITH INSULIN GLARGINE AND INSULIN DETEMIR
    Guisasola, Alvarez F.
    Puente, Mauricio D.
    Coscolin, Garcia T.
    Terres, Rubio C.
    VALUE IN HEALTH, 2010, 13 (07) : A287 - A287
12345